{"id":53044,"date":"2023-01-18T17:03:42","date_gmt":"2023-01-18T16:03:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/"},"modified":"2023-01-18T17:03:42","modified_gmt":"2023-01-18T16:03:42","slug":"correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/","title":{"rendered":"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health"},"content":{"rendered":"
\n

\nGloria Vanderham Appointed CEO and Michael Roth Named Chair of Bliss Bio Health and NPG Health<\/i><\/b>\n<\/p>\n

AUSTIN, Texas & NEW YORK–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe updated release reads:\n<\/p>\n

\nTHE NEXT PRACTICES GROUP AND THE BLISS GROUP LAUNCH LIFE SCIENCES COLLECTIVE AND COMMUNICATIONS FIRM, NPG HEALTH AND BLISS BIO HEALTH<\/b>\n<\/p>\n

\nGloria Vanderham Appointed CEO and Michael Roth Named Chair of Bliss Bio Health and NPG Health<\/i><\/b>\n<\/p>\n

\nToday, The Next Practices Group<\/a> (NPG) and The Bliss Group<\/a> announce the formation of NPG Health, a life sciences marketing and communications collective ignited by insights and informed by analysis to join clients in improving healthcare outcomes. NPG Health will launch alongside its first firm, Bliss Bio Health, a new life sciences marketing and communications company headquartered in Holmdel, New Jersey. Industry veteran Gloria Vanderham will lead both NPG Health and Bliss Bio Health as Chief Executive Officer to help clients across the health continuum disrupt the healthcare ecosystem and remove barriers to optimal care with an unrelenting focus on the whole person and their health journey.\n<\/p>\n

\n\u201cOur goal is to build a one-stop solution from \u2018atom to access\u2019 that services our clients at the global level,\u201d said Bob Pearson, Chair of The Next Practices Group and CEO of The Bliss Group. \u201cNPG Health is our platform and Bliss Bio Health is our first firm. This is why we are thrilled to partner with Gloria, who will start us on the path of building a next generation healthcare firm.\u201d\n<\/p>\n

\nVanderham is an industry recognized and values driven leader who has more than two decades of global, regional and local country experience in communications, digital and social media marketing. She understands the challenges and opportunities from the agency and in-house perspectives and brings invaluable patient insights to drive business impact for our clients and strong leadership for our teams.\n<\/p>\n

\nMost recently, Gloria Vanderham lived in Basel, Switzerland where she was Region Europe Head of Communications at Novartis AG. Previous roles include leadership positions at Novartis Pharmaceuticals, Johnson & Johnson and Fleishman-Hillard. Gloria is a Rutgers University alumna, member of the Healthcare Businesswomen\u2019s Association and current Vice Chair of the Executive Committee of the Rutgers University Alumni Association Board of Directors.\n<\/p>\n

\n\u201cIt is an honor to lead Bliss Bio Health and NPG Health. I am energized by the teams\u2019 exemplary talent, passion, agility, entrepreneurial spirit and alignment with our purpose to make a measurable difference for people living with a disease.\u201d Gloria Vanderham said. \u201cWe have a responsibility to do better and offer unique approaches that promote clarity, collaboration and collective healthcare ecosystem progress. We will attract team members, partners and clients who want to be a part of the solution.\u201d\n<\/p>\n

\nMichael Roth, Founder and Managing Partner at The Bliss Group, who created and shaped its healthcare vertical, will take on the role of Chair of Bliss Bio Health and NPG Health.\n<\/p>\n

\n\u201cThe presence of healthcare marketing and communications teams who truly understand the science, patient experience and the business of health\u2014equally\u2014is paramount to the evolution of the industry,\u201d Michael Roth said. \u201cOver the years, we learned that the integration of these three disciplines leads to a real white space in healthcare. From powering clinical trials through our CTRx Pathways<\/a> program and creating compelling integrated campaigns to advocating for equity in healthcare access and driving healthcare policy communications, we\u2019re enabling better outcomes in care.\u201d\n<\/p>\n

\nNPG Health and Bliss Bio Health will focus on early science, R&D research, medical education and advertising, commercialization, health programs and reimbursement. They will unite strategies for clients, spot trends in the industry, enable collaboration with new partners and facilitate fully integrated innovative advertising, marketing, public affairs and communications programs. The firms\u2019 innovation offerings range from data science and analytics to paid media to purpose via more than 180 team members within NPG.\n<\/p>\n

\nGloria Vanderham will begin as Chief Executive Officer effective February 1. To learn more about Bliss Bio Health and NPG Health, visit BlissBioHealth.com<\/a>.\n<\/p>\n

\nAbout The Next Practices Group<\/b>\n<\/p>\n

\nNPG is a founder-driven group formed to create perpetual competitive advantage and value for clients. The group\u2019s combined expertise in leading organizations and in the key disciplines of data science, technology, digital media, issues management, cybersecurity, and marketing communications powers new models and a new approach to doing business.\n<\/p>\n

\nAbout The Bliss Group<\/b>\n<\/p>\n

\nThe Bliss Group is an insight-driven marketing communications agency that blends data science with the art of storytelling to target priority audiences with precision, empathy and purpose. We specialize in building value for clients in the healthcare, financial, technology, business and professional services sectors. Our approach is grounded in data and guided by deep industry experience. Powered by proprietary algorithms and innovative media models, we tell stories across mediums that inspire action and make an impact. For more information, please visit https:\/\/www.theblissgrp.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Marisha Chinsky, The Bliss Group
\n
MChinsky@theblissgrp.com
\n
<\/a>917-865-5791\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Gloria Vanderham Appointed CEO and Michael Roth Named Chair of Bliss Bio Health and NPG Health AUSTIN, Texas & NEW YORK–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: THE NEXT PRACTICES GROUP AND THE BLISS GROUP LAUNCH LIFE SCIENCES COLLECTIVE AND COMMUNICATIONS FIRM, NPG HEALTH … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53044","6":"format-standard","7":"category-industry"},"yoast_head":"\nCORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Gloria Vanderham Appointed CEO and Michael Roth Named Chair of Bliss Bio Health and NPG Health AUSTIN, Texas & NEW YORK–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: THE NEXT PRACTICES GROUP AND THE BLISS GROUP LAUNCH LIFE SCIENCES COLLECTIVE AND COMMUNICATIONS FIRM, NPG HEALTH ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-18T16:03:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230118005297\/en\/1688726\/21\/Gloria_V.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health\",\"datePublished\":\"2023-01-18T16:03:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/\"},\"wordCount\":850,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005297\\\/en\\\/1688726\\\/21\\\/Gloria_V.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/\",\"name\":\"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005297\\\/en\\\/1688726\\\/21\\\/Gloria_V.jpg\",\"datePublished\":\"2023-01-18T16:03:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005297\\\/en\\\/1688726\\\/21\\\/Gloria_V.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005297\\\/en\\\/1688726\\\/21\\\/Gloria_V.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/","og_locale":"en_US","og_type":"article","og_title":"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health - Pharma Trend","og_description":"Gloria Vanderham Appointed CEO and Michael Roth Named Chair of Bliss Bio Health and NPG Health AUSTIN, Texas & NEW YORK–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: THE NEXT PRACTICES GROUP AND THE BLISS GROUP LAUNCH LIFE SCIENCES COLLECTIVE AND COMMUNICATIONS FIRM, NPG HEALTH ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-18T16:03:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230118005297\/en\/1688726\/21\/Gloria_V.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health","datePublished":"2023-01-18T16:03:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/"},"wordCount":850,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005297\/en\/1688726\/21\/Gloria_V.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/","url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/","name":"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005297\/en\/1688726\/21\/Gloria_V.jpg","datePublished":"2023-01-18T16:03:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230118005297\/en\/1688726\/21\/Gloria_V.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230118005297\/en\/1688726\/21\/Gloria_V.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-the-next-practices-group-and-the-bliss-group-launch-life-sciences-collective-and-communications-firm-npg-health-and-bliss-bio-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CORRECTING\u00a0and\u00a0REPLACING\u00a0The Next Practices Group and The Bliss Group Launch Life Sciences Collective and Communications Firm, NPG Health and Bliss Bio Health"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53044"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53044\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}